Evidence map›Paper›PMID 39189763›Full record

ArticleMicrobiology spectrum2024

Evaluation of human antibodies from vaccinated volunteers for protection against

Li Zhang, Binyang Zheng, Jing Lu, Haisheng Wu, Hailian Wu, Qi Zhang, Lei Jiao, Hongxing Pan, Jianfang Zhou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Virulence Reduction inBiomolecules · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Li ZhangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.ORCID 0000-0002-0953-125X
Binyang ZhengJiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Jing LuJiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Haisheng WuQinghai Institute for Endemic Disease Control and Prevention, Xining, China.
Hailian WuQinghai Institute for Endemic Disease Control and Prevention, Xining, China.
Qi ZhangQinghai Institute for Endemic Disease Control and Prevention, Xining, China.
Lei JiaoLanzhou Institute of Biological Products Co., Ltd., State Key Laboratory of Novel Vaccines for Emerging Infectious Diseases, Lanzhou, China.
Hongxing PanJiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Jianfang ZhouNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.ORCID 0009-0009-6719-7155

Funding

MOST | National Key Research and Development Program of China (NKPs)；The Social development Project ofJiangsu Provience 2022YFC2604100；BE2020720
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, BacterialAntibodies, MonoclonalMice, Inbred BALB CPlaguePlague VaccineYersinia pestisAnimalsAntigens, BacterialBacterial ProteinsEpitopesFemaleHumansMiceVaccinationVaccines, SubunitAntibodies, BacterialAntibodies, MonoclonalAntigens, BacterialBacterial Proteinscaf1 protein, Yersinia pestisEpitopesPlague VaccineVaccines, Subunitanimal protectionfraction 1 capsular antigenhuman monoclonal antibodyphage displayYersinia pesti

Identifiers

PMID39189763
PMCPMC11448073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.